Efficacy observation on Governor Vessel-regulating and brain-unblocking acupuncture for post-stroke depression
10.1007/s11726-016-0920-8
- VernacularTitle:调督通脑针刺法治疗中风后抑郁疗效观察
- Author:
Lihua ZHANG
;
Yanchun ZHANG
;
Yanjun WANG
;
Yixu HAN
;
Pengpeng LI
- Publication Type:Journal Article
- Keywords:
Acupuncture Therapy;
Stroke;
Complications;
Depression;
Activities of Daily Living
- From:
Journal of Acupuncture and Tuina Science
2016;14(3):175-180
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the clinical effect of Governor Vessel-regulating and brain-unblocking acupuncture on post-stroke depression.
Methods:A total of 70 eligible cases were randomly allocated into an observation group and a control group according to the random number table. Patients in the observation group were treated with Governor Vessel-regulating and brain-unblocking acupuncture, whereas patients in the control group were treated with oral Escitalopram Oxalate tablet. The treatment lasted for 8 weeks. The Hamilton depression scale (HAMD), Montgomery Asberg depression rating scale (MADRS), and Barthel Index (BI) were used to evaluate the patients’ condition before, 4 weeks and 8 weeks after treatment respectively. In addition, adverse reactions were also recorded.
Results:After 4 weeks of treatment, the HAMD and MADRS scores were significantly decreased in both groups (P<0.05); and the BI scores were significantly increased in both groups (P<0.05). There was no between-group statistical difference in HAMD score (P>0.05); the MADRS score in the observation group was significantly lower than that in the control group (P<0.05) and the BI score in the observation group was significantly higher than that in the control group (P<0.05). After 8 weeks of treatment, there were no between-group statistical differences in all aspects (P>0.05); however, the adverse reactions in the observation group were significantly less than those in the control group.
Conclusion:The Governor Vessel-regulating and brain-unblocking acupuncture is safe and effective for post-stroke depression and can obtain similar efficacy as Escitalopram Oxalate tablet. In addition, it can fast alleviate core symptoms of depression and improve the activities of daily living (ADL) and has fewer adverse reactions.
